指南与共识耳科与耳神经

临床实践指南:年龄相关性听力损失执行摘要

Clinical Practice Guideline: Age-Related Hearing Loss Executive Summary.
指南 / 共识 · Otolaryngol Head Neck Surg · 2024-01-01

本指南针对50岁及以上人群的年龄相关性听力损失,由指南制定小组提出11条关键行动声明,其中3条为强推荐(听力筛查异常后获取或转诊进行听力图检查、提供或转诊进行助听器验配、助听器验配后仍存在言语识别困难者转诊评估人工耳蜗植入资格),7条为推荐,1条为可选。目标读者为所有诊疗环境中的临床医生。

要点

  • 对50岁及以上人群在就诊时进行听力损失筛查(推荐)。
  • 筛查提示听力损失者应获取或转诊进行听力图检查(强推荐)。
  • 应为年龄相关性听力损失患者提供或转诊进行适配合适的助听器(强推荐)。

核心结论

  • 指南旨在识别质量改进机会,为临床医生提供关于年龄相关性听力损失识别和管理的可信赖的循证推荐。
  • 指南针对50岁及以上个体,目标受众为所有诊疗环境中的临床医生。
  • 指南不旨在成为年龄相关性听力损失管理的全面通用指南,也不限制临床医生基于经验和个体评估提供的诊疗。

研究设计与样本

  • 指南制定小组(GDG)制定,发表于《耳鼻咽喉头颈外科杂志》(Otolaryngol Head Neck Surg)。
  • 目标患者为任何50岁及以上个体,目标受众为所有诊疗环境中的所有临床医生。
  • 通过明确的可操作声明、文献支持说明、证据质量评价和实施推荐来传达质量改进机会。

主要发现

  • 年龄相关性听力损失(ARHL)在50岁及以上人群中常见但常被诊断不足和治疗不足,与痴呆、抑郁、心血管疾病和跌倒等健康风险相关。
  • GDG对以下关键行动声明(KAS)做出强推荐:KAS 4、KAS 8、KAS 9。
  • GDG对以下KAS做出推荐:KAS 1、KAS 2、KAS 3、KAS 5、KAS 6、KAS 7、KAS 10。
  • GDG将KAS 11作为可选提供。

关键数值与推荐

  • 强推荐(KAS 4):如果筛查提示听力损失,临床医生应获取或转诊至能够获取听力图的临床医生。
  • 强推荐(KAS 8):临床医生应向年龄相关性听力损失患者提供或转诊至能够提供适配合适的助听器验配的临床医生。
  • 强推荐(KAS 9):当患者已适配合适的助听器但仍存在持续性听力困难且言语理解差时,临床医生应转诊患者进行人工耳蜗植入资格评估。
  • 推荐(KAS 1):临床医生应在医疗就诊时对50岁及以上患者进行听力损失筛查。
  • 推荐(KAS 2):如果筛查提示听力损失,临床医生应使用耳镜检查耳道和鼓膜,或转诊至能够检查耳部以排查耵聍栓塞、感染或其他异常的临床医生。

临床怎么用

  • 临床医生应在医疗就诊时对50岁及以上患者筛查听力损失(推荐)。
  • 筛查提示听力损失时,应获取或转诊进行听力图检查(强推荐),并检查耳道和鼓膜或转诊排查耵聍栓塞、感染等(推荐)。
  • 应识别影响听力保健可及性的社会人口学因素和患者偏好(推荐)。
  • 应提供或转诊进行适配合适的助听器(强推荐),并就沟通策略和辅助听力设备进行咨询(推荐)。
  • 助听器验配后仍存在持续性听力困难且言语理解差者,应转诊评估人工耳蜗植入资格(强推荐)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Age-related hearing loss (ARHL) is a prevalent but often underdiagnosed and undertreated condition among individuals aged 50 and above. It is associated with various sociodemographic factors and health risks including dementia, depression, cardiovascular disease, and falls. While the causes of ARHL and its downstream effects are well defined, there is a lack of priority placed by clinicians as well as guidance regarding the identification, education, and management of this condition. PURPOSE: The purpose of this clinical practice guideline is to identify quality improvement opportunities and provide clinicians trustworthy, evidence-based recommendations regarding the identification and management of ARHL. These opportunities are communicated through clear actionable statements with an explanation of the support in the literature, the evaluation of the quality of the evidence, and recommendations on implementation. The target patients for the guideline are any individuals aged 50 years and older. The target audience is all clinicians in all care settings. This guideline is intended to focus on evidence-based quality improvement opportunities judged most important by the Guideline Development Group (GDG). It is not intended to be a comprehensive, general guide regarding the management of ARHL. The statements in this guideline are not intended to limit or restrict care provided by clinicians based on their experience and assessment of individual patients. ACTION STATEMENTS: The GDG made strong recommendations for the following key action statements (KASs): (KAS 4) If screening suggests hearing loss, clinicians should obtain or refer to a clinician who can obtain an audiogram. (KAS 8) Clinicians should offer, or refer to a clinician who can offer, appropriately fit amplification to patients with ARHL. (KAS 9) Clinicians should refer patients for an evaluation of cochlear implantation candidacy when patients have appropriately fit amplification and persistent hearing difficulty with poor speech understanding. The GDG made recommendations for the following KASs: (KAS 1) Clinicians should screen patients aged 50 years and older for hearing loss at the time of a health care encounter. (KAS 2) If screening suggests hearing loss, clinicians should examine the ear canal and tympanic membrane with otoscopy or refer to a clinician who can examine the ears for cerumen impaction, infection, or other abnormalities. (KAS 3) If screening suggests hearing loss, clinicians should identify sociodemographic factors and patient preferences that influence access to and utilization of hearing health care. (KAS 5) Clinicians should evaluate and treat or refer to a clinician who can evaluate and treat patients with significant asymmetric hearing loss, conductive or mixed hearing loss, or poor word recognition on diagnostic testing. (KAS 6) Clinicians should educate and counsel patients with hearing loss and their family/care partner(s) about the impact of hearing loss on their communication, safety, function, cognition, and quality of life. (KAS 7) Clinicians should counsel patients with hearing loss on communication strategies and assistive listening devices. (KAS 10) For patients with hearing loss, clinicians should assess if communication goals have been met and if there has been improvement in hearing-related quality of life at a subsequent health care encounter or within 1 year. The GDG offered the following KAS as an option: (KAS 11) Clinicians should assess hearing at least every 3 years in patients with known hearing loss or with reported concern for changes in hearing.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Tsai Do BS, Bush ML, Weinreich HM, et al. Clinical Practice Guideline: Age-Related Hearing Loss Executive Summary. Otolaryngol Head Neck Surg. 2024. PMID: 38682789. doi:10.1002/ohn.749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。